EverSource Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Sell
1,130
-192
-15% -$3.35K ﹤0.01% 2562
2026
Q1
$25.3K Buy
1,322
+271
+26% +$5.89K ﹤0.01% 2360
2025
Q4
$23.1K Buy
1,051
+472
+82% +$8.52K ﹤0.01% 2290
2025
Q3
$7.03K Buy
579
+410
+243% +$5.55K ﹤0.01% 2991
2025
Q2
$3.15K Buy
169
+130
+333% +$2.58K ﹤0.01% 3334
2025
Q1
$747 Sell
39
-229
-85% -$6.7K ﹤0.01% 3329
2024
Q4
$9.65K Buy
268
+25
+10% +$846 ﹤0.01% 2014
2024
Q3
$10.3K Sell
243
-12
-5% -$509 ﹤0.01% 1847
2024
Q2
$9.43K Buy
255
+12
+5% +$501 ﹤0.01% 1890
2024
Q1
$8.92K Sell
243
-10
-4% -$268 ﹤0.01% 1751
2023
Q4
$7.48K Buy
253
+243
+2,430% +$5.04K ﹤0.01% 1692
2023
Q3
$208 Hold
10
﹤0.01% 2441
2023
Q2
$245 Hold
10
﹤0.01% 2411
2023
Q1
$406 Hold
10
﹤0.01% 2272
2022
Q4
$450 Sell
10
-10
-50% -$453 ﹤0.01% 2224
2022
Q3
$1K Hold
20
﹤0.01% 1900
2022
Q2
$1K Hold
20
﹤0.01% 1676
2022
Q1
$2K Buy
20
+10
+100% +$1.17K ﹤0.01% 1589
2021
Q4
$2K Buy
+10
New +$1.35K ﹤0.01% 1635

Other funds holding TNDM

EverSource Wealth Advisors's TNDM Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Tandem Diabetes Care (TNDM) stake by 15% in Q2 2026, selling an estimated $3.35K and leaving 1,130 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

EverSource Wealth Advisors first reported a position in TNDM in Q4 2021 and has held it in 19 quarters since. The position peaked at $25.3K in Q1 2026. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • EverSource Wealth Advisors held 1,130 shares of Tandem Diabetes Care worth $17.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 192 Tandem Diabetes Care shares in Q2 2026, an estimated $3.35K.
  • Tandem Diabetes Care made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2562 holding.
  • EverSource Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Tandem Diabetes Care position peaked at $25.3K in Q1 2026.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.